These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 100806)

  • 1. High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.
    Whitaker PM; Seeman P
    Psychopharmacology (Berl); 1978 Sep; 59(1):1-5. PubMed ID: 100806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes.
    Waeber C; Schoeffter P; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):595-601. PubMed ID: 2975354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.
    Whitaker PM; Seeman P
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5783-7. PubMed ID: 32537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding.
    Schiavi GB; Brunet S; Rizzi CA; Ladinsky H
    Neuropharmacology; 1994; 33(3-4):543-9. PubMed ID: 7984293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ; Palmier C
    Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.
    Xiong WC; Nelson DL
    Life Sci; 1989; 45(16):1433-42. PubMed ID: 2811600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-Mianserin binding in calf caudate: possible involvement of serotonin receptors in anti-depressant drug action.
    Whitaker PM; Cross AJ
    Biochem Pharmacol; 1980 Oct; 29(19):2709-12. PubMed ID: 6107087
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug antagonism and reversibility of the binding of indoleamines in brain.
    Ungar F; Hitri A; Alivisatos SG
    Eur J Pharmacol; 1976 Mar; 36(1):115-25. PubMed ID: 1063074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of 5-hydroxytryptamine1D binding sites by GTP and GTPgammaS.
    Harrington MA; Peroutka SJ
    Brain Res; 1990 Jan; 506(1):172-4. PubMed ID: 2405953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
    Rosenfeld MR; Makman MH
    J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a serotonin transporter and an adenylate cyclase-linked serotonin receptor in the cestode Hymenolepis diminuta.
    Ribeiro P; Webb RA
    Life Sci; 1987 Feb; 40(8):755-68. PubMed ID: 3027490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.
    Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M
    Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]Metergoline: a new ligand of serotonin receptors in the rat brain.
    Hamon M; Mallat M; Herbet A; Nelson DL; Audinot M; Pichat L; Glowinski J
    J Neurochem; 1981 Feb; 36(2):613-26. PubMed ID: 7463079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of synaptosomal neurotransmitter uptake by hallucinogens.
    Whipple MR; Reinecke MG; Gage FH
    J Neurochem; 1983 Apr; 40(4):1185-8. PubMed ID: 6131933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.